Publication

Abstract : Lung cancer has become the number one killer among cancers worldwide. It is a common malignancy globally amongst males as well as for both gender combined. No screening test is recommended to identify lung cancer patients at earlier stages, when the cure rates are much higher than that at more advanced stages. Thus, many lung cancers go undetected until they are advanced because individuals who have a long history of cigarette smoking are unlikely to notice the early symptoms of cough or dyspnoea. It is often symptoms associated with large tumours or metastatic disease that prompt medical attention. The present study was undertaken to determine the incidence of Lung cancer among patients, receiving treatment in Department of Oncology, in a tertiary Hospital. Both inpatients and outpatients were included in the study. Males (79%) were more frequently affected than females (21%); Peak incidence was in the 61-70 age groups. Based on the stage of tumour, (21%) of lung cancer were diagnosed at localised, (23%) at regional, (56%) at distant stage. Based on treatment pattern, majority undergone Radiotherapy (37%), followed by Chemotherapy (16%), Chemotherapy + Radiotherapy (16%), Surgery + Chemotherapy (9%), Surgery (8%), Surgery + Chemotherapy + Radiotherapy (7%), Surgery + Radiotherapy (7%).